Reference(s)
Click here to return to the Reference Table

Category: Carcinomas
Cancer type: Nasopharyngeal
Descriptor: HGF/SF expression


Reference Number: 104
Qian, C. N. et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 62, 589-96 (2002).
PubMed link      E-mail link

Reference Number: 596
Li Z, Lin SX, Liang HZ, He JH. [Expression of hepatocyte growth factor/c-Met system in nasopharyngeal carcinoma and its biological significance]
[Article in Chinese] Zhonghua Bing Li Xue Za Zhi. 34, 75-9 (2005)

PubMed link      E-mail link

Reference Number: 709
Lim YC, Park HY, Hwang HS, Kang SU, Pyun JH, Lee MH, Choi EC, Kim CH. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett. 271, 140-52 (2008) Epub 2008 Jul 15
PubMed link      E-mail link

Reference Number: 795
Xie LQ, Bian LJ, Li Z, Li Y, Liang YJ. Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma. Oncol Rep. 23, 141-50 (2010)
PubMed link      E-mail link

Reference Number: 796
Li-juan B, Bing L, Zhi L, Yang L, Ying-jie L. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression. Pathol Res Pract. 205, 828-37 (2009)
PubMed link      E-mail link

Reference Number: 801
Xie LQ, Bian LJ, Li Z, Li Y, Li ZX, Li B. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma. Ann Surg Oncol. 17, 1927-36 (2010)
PubMed link      E-mail link